The same research results also confirmed that the use of CRF1 antagonists can significantly increase vagus nerve (VN) activity and reduce sympathetic nerve (SN) activity, suggesting that the use of CRF1 antagonists is a potential method for treating IBD caused by ANS disorders (29). The gene discussed is CRHR1; the disease is inflammatory bowel disease.